• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ACADIA Pharmaceuticals Inc

+ Add to Watchlist


19.4400 USD 0.1600 0.83%

As of 20:10:00 ET on 04/17/2014.

Snapshot for ACADIA Pharmaceuticals Inc (ACAD)

Open: 19.1100 Day's Range: 18.3900 - 19.9700 Volume: 2,154,396
Previous Close: 19.2800 52wk Range: 11.2600 - 32.0000 1-Yr Rtn: +60.79%

Stock Chart for ACAD

No chart data available.
  • ACAD:US 19.4400
  • 1D
  • 1M
  • 1Y
Interactive ACAD Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACAD

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.4400
Est. EPS (USD) (12/2014) -0.5500
Est. PEG Ratio -
Market Cap (M USD) 1,895.45
Shares Outstanding (M) 97.50
30 Day Average Volume 2,491,146
Price/Book (mrq) -
Price/Sale (ttm) 1,409.6484
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACAD

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACAD

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Uli HacksellPresident/CEORoger M MillsExec VP:Dev/Chief Medical Ofcr
Glenn F BaityVP/Secy/General CounselTerrence O MooreExec VP/Chief Commercial Officer
More Company Profile & Key Executives for ACAD

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil